Mon. Sep 26th, 2022

HYDERABAD: Biological E. Ltd (BE) said on Thursday that it has delivered 10 crore (100 million) doses of its Covid-19 vaccine, Corbevax to the Center so far.
In a statement, the city-based vaccine manufacturer said: “Biological E. Limited has delivered 10 million doses of Corbevax to the Government of India so far. The India-wide rollout of Corbevax in children aged 12-14 years began on 16 March 2022 and so far almost seven million doses have been administered and 2.9 million children have completed the vaccination regimen. two doses.
Corbevax was also approved by the Union Ministry of Health as a heterologous booster dose of Covid-19 under emergency use authorization for people over 18 years of age after 6 months of primary vaccination administration (two doses) of Covaxin or Covishield, the company said.
The approval of the Ministry of Health is based on the recommendations made recently by the Covid-19 Workgroup of National Technical Advisory Group on Immunizations (NTAGI).
Corbevax is expected to be available as a booster dose in the CoWIN app at public and private vaccination centers from August 12, 2022.
This approval came after the Drug Comptroller General of India (DCGI) approved the vaccine for emergency use as a heterologous booster dose of Covid-19 for persons 18 years of age or older on June 4, 2022.
The vaccine had received emergency use authorization as a two-dose primary vaccination schedule in Adults, Adolescents, and Children five years of age and older, in a series of approvals from December 2021 to April 2022.
Corbevax price for private Covid-19 vaccination centers is Rs. 250 including GST. For the end user, the price was set at Rs 400, including taxes and administrative charges.

Read More: 100 million doses of Corbevax supplied to Centre: Biological E Ltd | India News